Indices hit day's low; market breadth positive

Image
Capital Market
Last Updated : Nov 09 2021 | 10:50 AM IST
Indices hit the day's low in morning trade. The Nifty slipped below 18,050 level. Auto, pharma and PSU banks stocks rallied while FMCG shares declined.

At 10:26 IST, the barometer index, the S&P BSE Sensex, was down 146.18 points or 0.24% to 60,399.54. The Nifty 50 index fell 32 points or 0.18% to 18,036.55.

The broader market outperformed. The S&P BSE Mid-Cap index gained 0.81% while the S&P BSE Small-Cap index added 0.67%.

The market breadth was positive. On the BSE, 1946 shares rose and 1033 shares fell. A total of 166 shares were unchanged.

Results Today:

Mahindra & Mahindra (up 1.5%), Power Grid Corporation of India (down 0.71%), Bharat Heavy Electricals (up 0.89%), Bosch (up 2.25%), Indraprastha Gas (up 0.3%), Petronet LNG (up 0.56%), HEG (up 0.48%), Hindustan Copper (up 0.48%) and VST Tillers Tractors (up 0.59%) are among the companies scheduled to post their quarterly results today.

Buzzing Index:

The Nifty Auto index gained 1.37% to 11,805.1, rising for third trading session. The auto index surged 3.54% in three days.

TVS Motor (up 9.65%), Ashok Leyland (up 3.12%), Tata Motors (up 2.71%), Bosch (up 2%), Mahindra & Mahindra (up 1.6%), Bajaj Auto (up 1.35%) and Hero MotoCorp (up 1.09%) were top gainers in automobile space.

Stocks in Spotlight:

Shyam Metalics and Energy fell 0.12%. The company reported 157% jump in consolidated net profit to Rs 410.3 crore in Q2 FY22 from Rs 159.6 crore in Q2 FY21. Revenues in the second quarter increased by 87% to Rs 2,494.3 crore from Rs 1,335.2 recorded in the same period last year. EBITDA in Q2 FY22 was Rs 624 crore, up by 140% from Rs 260.3 crore in Q2 FY21. EBITDA margin was 25% in Q2 FY22 as against 19.5% in Q2 FY21.

Vijaya Diagnostic Centre rose 1.02% after the company reported a 5% rise in consolidated net profit to Rs 27.71 crore as revenue from operations remained flat at Rs 112.71 crore in Q2 FY22 over Q2 FY21. Non-COVID revenue was up by 22% YoY to Rs 104.3 crore and COVID revenue (RT-PCR & Antibody tests) declined 70% YoY to Rs 8.4 crore during the quarter. EBITDA in Q2 FY22 was Rs 51.15 crore. The company had reported an EBITDA of Rs 51.29 crore in Q2 FY21. EBITDA margin in the second quarter was 45.4% as against 45.3% in the same period last year.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 09 2021 | 10:24 AM IST

Next Story